22NW LP’s LianBio American Depositary Shares LIAN Stock Holding History

22NW LP’s Portfolio LIAN Stock Details LIAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,211,678	Closed	-$9.89M	–	14
2023 Q4	$9.89M	Hold	2,211,678	–	–	6.44%	6
2023 Q3	$3.3M	Buy	2,211,678 +2,070,455	+1,466%	+$3.94M	2.35%	12
2023 Q2	$322K	Hold	141,223	–	–	0.2%	14
2023 Q1	$277K	Hold	141,223	–	–	0.17%	17
2022 Q4	$232K	Hold	141,223	–	–	0.13%	19
2022 Q3	$282K	Hold	141,223	–	–	0.16%	20
2022 Q2	$305K	Buy	+141,223	New	+$480K	0.16%	20

Other funds holding LIAN

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

22NW LP's LIAN Position: Q1 2024 in Review

22NW LP sold out of LianBio American Depositary Shares (LIAN) in Q1 2024, closing a stake of 2,211,678 shares — an estimated $9.89M sold.

22NW LP first reported a position in LIAN in Q2 2022 and held it in 7 quarters. The position peaked at $9.89M in Q4 2023. 3 funds tracked by Wall St. Rank hold LIAN as of Q1 2024.

22NW LP reported no remaining LianBio American Depositary Shares position as of Q1 2024 after selling out during the quarter.
22NW LP sold 2,211,678 LianBio American Depositary Shares shares in Q1 2024, an estimated $9.89M.
22NW LP first reported a position in LianBio American Depositary Shares in Q2 2022 and held it in 7 quarters.
22NW LP's LianBio American Depositary Shares position peaked at $9.89M in Q4 2023.
3 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q1 2024.

Based on 22NW LP's 13F filing for Q1 2024, filed 15 May 2024.